Plant-Produced Recombinant Humaninterleukin-2
Print
EmailRecombinant human interleukin-2 (rhIL-2) is a biopharmaceutical protein of great importance, asit is the standard FDA-approved immunotherapeutic treatment for end-stage metastatic melanomaand renal cell cancer.
Find out more about this topic in this article.
Did you find this article useful?
You Might Also Be Interested In
-
CANR student Ashley Prince talks with the Class of 2021 about resilience, empowerment and growth.
Published on May 18, 2021
-
Biosystems engineering student uses problem-solving skills to land internship at Goldman Sachs
Published on September 1, 2021
-
Biosystems engineering student finds her place at MSU
Published on August 30, 2021
-
Biosystems engineering student hopes to open free clinic in Africa
Published on February 25, 2021
-
MSU named Top 10 agriculture and forestry college in new report
Published on March 23, 2021
